Previous Close | 217.02 |
1-Year Change | 5.25% |
6-Months Change | 8.76% |
3-Months Change | 18.43% |
Moving Avg (50d) | 207.07 |
Moving Avg (200d) | 204.22 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 34.8B |
Beta (3-Years) | 1.19 |
Revenue Growth (ttm) | 11.56% |
Net Profit Margin (ttm) | 24.2% |
Return On Assets (ttm) | 10.33% |
EPS (ttm) | 3.32 |
PE Ratio (ttm) | 65.37 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Services |
Country: | United States |
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It works with software as a service in the life-science industry. The company went public in October 2013. As of May 5, 2022, it has a market capitalization of US$27.5 billion. On... Wikipedia